Warning letter
Lex, Inc.: warning letter of Dec 7, 2004
FDA warning letter UCM146696 · Florida District Office
Key facts
| Reference number | UCM146696 |
|---|---|
| Company | Lex, Inc. |
| Subject | CGMP for Drugs/Manufacture, Processing, Packing, Holding/Adulterated/Misbranded |
| Issue date | Dec 7, 2004 |
| Posted date | Dec 7, 2004 |
| Issuing office | Florida District Office |
| Product type | Drugs |
| CFR sections cited | 341.74(d)(1)(iii), 201.5, 201.21, 201.66, 211, 211.166, 211.192, 331, 333, 333.210, 333.250, 333.310 and 29 more |
| Country | 3 |
| Letter on fda.gov | web.archive.org |
At a glance
- 10–99 CFR sections cited
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: